|
A systematic review of six studies comprising 1371 men evaluated the impact of alfuzosin on ejaculatory function while treating BPH/LUTS, using two questionnaires: IPSS and MSHQ-EjD-SF. |
Alfuzosin treatment led to a significant reduction in IPSS scores, with a median decrease of 6.6 points, range: 2.5–9.3.
Most studies showed LUTS improvement within 6 months, with one study reporting results as early as 3 months.
Sustained improvement in IPSS scores was observed over 2 years of alfuzosin treatment in one study.
Alfuzosin treatment resulted in increased MSHQ-EjD-SF scores, indicating improved ejaculatory function.
Alfuzosin led to a median increase of MSHQ-EjD-SF score by 1.9 points, range: 0.9–5.8.
One study demonstrated a sustained improvement in MSHQ-EjD-SF scores ~2 years with a mean increase of 5.
Alfoo-Improved Pharmacokinetics
ALFOO, containing Alfuzosin molecule, is Anti-BPH which helps in treatment of LUTS due to BPH in Young Sexually Active Male in 40-60 year old age group
